<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Quantum Discovery Labs &#187; kinase</title>
	<atom:link href="http://q-pharm.com/category/kinase/feed/" rel="self" type="application/rss+xml" />
	<link>http://q-pharm.com</link>
	<description>The drug discovery company</description>
	<lastBuildDate>Fri, 02 Mar 2012 06:38:21 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Docking validation study: PDK1-kinase (oncology)</title>
		<link>http://q-pharm.com/2008/06/docking-validation-study-pdk1-kinase-oncology/</link>
		<comments>http://q-pharm.com/2008/06/docking-validation-study-pdk1-kinase-oncology/#comments</comments>
		<pubDate>Sat, 07 Jun 2008 05:02:00 +0000</pubDate>
		<dc:creator>fedichev</dc:creator>
				<category><![CDATA[docking]]></category>
		<category><![CDATA[IC50]]></category>
		<category><![CDATA[kinase]]></category>
		<category><![CDATA[oncology]]></category>
		<category><![CDATA[PDK1]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=31</guid>
		<description><![CDATA[Following the classic thrombine study, we catch up with a more important target: PDK1 kinase. Pyruvate dehydrogenase kinase, isozyme 1, also known as PDK1, is a human gene.It codes for...
Related posts:<ol>
<li><a href='http://q-pharm.com/2008/06/docking-validation-study-classic-example-thrombine/' rel='bookmark' title='Docking validation study: classic example, thrombine'>Docking validation study: classic example, thrombine</a></li>
<li><a href='http://q-pharm.com/2007/04/docking-selectivity-additive-vs-non-additive-force-field/' rel='bookmark' title='Docking selectivity: Additive vs. non-additive force field'>Docking selectivity: Additive vs. non-additive force field</a></li>
<li><a href='http://q-pharm.com/quantum-discovery-services/compound-profiling-prediction/' rel='bookmark' title='Compound Profiling Prediction'>Compound Profiling Prediction</a></li>
<li><a href='http://q-pharm.com/2008/05/protein-flexibility-and-false-positives-detection/' rel='bookmark' title='Protein Flexibility and False Positives detection.'>Protein Flexibility and False Positives detection.</a></li>
</ol>]]></description>
		<wfw:commentRss>http://q-pharm.com/2008/06/docking-validation-study-pdk1-kinase-oncology/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

